Posted
by diabetesMD at
6/3/2012 4:16 PM GMT
on bmj.com
The FDA has just added warnings to statins regarding their risks of increasing diabetes, memory loss or confusion and muscle damage. ( http://1.usa.gov/x3VO6H ). This is part of FDA’s recent efforts to be more proactive regarding potential risks of drugs and it was posted on their consumer site. None of ... Read More »
Posted
by Joey Rio at
24/2/2012 6:05 AM GMT
on bmj.com
Hello Alice: A few days ago I posted a thread about this: Is There a Real Epidemic of Bipolar Disease? Even after e-mailing you through doc2doc I got no answers from you. As I said before I get many referrals of Hypertensives and Diabetics with resistant hypertension, overweight, metabolic syndrome, and obesity taking ... Read More »
Posted
by Joey Rio at
22/2/2012 12:55 PM GMT
on bmj.com
Hello Fellows: We all know that there is a whole bunch of new and expensive anti-diabetic drugs entering the market. Mostly, if not all are still unsafe and with no proved long-term cardiovascular benefits. They are also mostly advertised through the achievement of lowering HBA1C levels, nowadays considered by many ... Read More »
Posted
by Joey Rio at
20/2/2012 12:42 PM GMT
on bmj.com
Hello Fellows: London, UK - New contraindications and warnings for medicines with aliskiren (Rasilez/Tekturna, Novartis) are among the opinions arising from the February 13-16 meeting of the European Medicines Agency 's (EMA) Committee for Medicinal Products for Human Use ... Read More »
Posted
by Joey Rio at
17/2/2012 6:49 PM GMT
on bmj.com
Hello Fellows: We all know that type 1 and type 2 diabetes mellitus are quite different disease states, beyond the common occurrence of Hyperglicaemia. Nowadays the strict or agressive control of fasting blood glucose or HBA1C levels is being progressively abandoned because below a safety level of these surrogates for ... Read More »